VirnetX (VHC) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $10.99, +0.73% vs the prior close of $10.91.
- Volume 4.80K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VHC rises 0.7% to $10.99. Closed at $10.99, +0.73% vs the prior close of $10.91. Day range $10.91β$11.05, opened at $10.91.
VHC daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β VHC rises 0.7% to $10.99
- Closed at $10.99, +0.73% vs the prior close of $10.91. Day range $10.91β$11.05, opened at $10.91.
- Volume was 4.80K shares, 0.1x its 50-day average of 71.14K β lighter than usual.
- Price is -10.4% vs its 50-day average ($12.26) and -24.3% vs its 200-day average ($14.51).
- 52-week range $8.41β$29.00; today's close sits at 13% of that range, 62.1% below the 52-week high.
Oct 14, 2026 β VHC dips 0.5% to $10.91, 4 down days in a row
- Closed at $10.91, -0.46% vs the prior close of $10.96. Day range $10.78β$11.08, opened at $10.90.
- Volume was 8.20K shares, 0.1x its 50-day average of 71.57K β lighter than usual.
- Price is -11.6% vs its 50-day average ($12.35) and -25.0% vs its 200-day average ($14.54).
- 52-week range $8.41β$29.00; today's close sits at 12% of that range, 62.4% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 β VHC dips 0.5% to $10.96, 3 down days in a row
- Closed at $10.96, -0.54% vs the prior close of $11.02. Day range $10.25β$11.11, opened at $11.09.
- Volume was 10.60K shares, 0.1x its 50-day average of 71.83K β lighter than usual.
- Price is -11.6% vs its 50-day average ($12.40) and -24.8% vs its 200-day average ($14.58).
- 52-week range $8.41β$29.00; today's close sits at 12% of that range, 62.2% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 β VHC slides 4.2% to $11.02
- Closed at $11.02, -4.17% vs the prior close of $11.50. Day range $10.31β$11.58, opened at $11.34.
- Volume was 12.20K shares, 0.2x its 50-day average of 71.67K β lighter than usual.
- Price is -11.5% vs its 50-day average ($12.45) and -24.6% vs its 200-day average ($14.62).
- 52-week range $8.41β$29.00; today's close sits at 13% of that range, 62.0% below the 52-week high.
Oct 9, 2026 β VHC slides 6.5% to $11.50
- Closed at $11.50, -6.50% vs the prior close of $12.30. Day range $11.22β$12.60, opened at $11.79.
- Volume was 17.00K shares, 0.2x its 50-day average of 71.47K β lighter than usual.
- Price is -7.9% vs its 50-day average ($12.49) and -21.5% vs its 200-day average ($14.65).
- 52-week range $8.41β$29.00; today's close sits at 15% of that range, 60.3% below the 52-week high.
Oct 8, 2026 β VHC jumps 4.1% to $12.30
- Closed at $12.30, +4.15% vs the prior close of $11.81. Day range $11.34β$12.42, opened at $11.34.
- Volume was 40.90K shares, 0.6x its 50-day average of 70.72K β lighter than usual.
- Price is -1.8% vs its 50-day average ($12.52) and -16.2% vs its 200-day average ($14.68).
- 52-week range $8.41β$29.00; today's close sits at 19% of that range, 57.6% below the 52-week high.
Oct 7, 2026 β VHC dips 1.3% to $11.81
- Closed at $11.81, -1.25% vs the prior close of $11.96. Day range $11.15β$12.00, opened at $11.99.
- Volume was 19.30K shares, 0.3x its 50-day average of 70.72K β lighter than usual.
- Price is -5.8% vs its 50-day average ($12.53) and -19.7% vs its 200-day average ($14.71).
- 52-week range $8.41β$29.00; today's close sits at 17% of that range, 59.3% below the 52-week high.
Oct 6, 2026 β VHC jumps 5.7% to $11.96, 3 up days in a row
- Closed at $11.96, +5.65% vs the prior close of $11.32. Day range $11.39β$12.01, opened at $11.43.
- Volume was 13.30K shares, 0.2x its 50-day average of 71.00K β lighter than usual.
- Price is -4.7% vs its 50-day average ($12.56) and -18.8% vs its 200-day average ($14.74).
- 52-week range $8.41β$29.00; today's close sits at 17% of that range, 58.8% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 β VHC jumps 8.0% to $11.32
- Closed at $11.32, +8.02% vs the prior close of $10.48. Day range $10.38β$11.74, opened at $10.38.
- Volume was 14.20K shares, 0.2x its 50-day average of 70.77K β lighter than usual.
- Price is -9.9% vs its 50-day average ($12.56) and -23.3% vs its 200-day average ($14.77).
- 52-week range $8.41β$29.00; today's close sits at 14% of that range, 61.0% below the 52-week high.
Oct 2, 2026 β VHC jumps 11.7% to $10.48
- Closed at $10.48, +11.73% vs the prior close of $9.38. Day range $9.51β$10.48, opened at $9.51.
- Volume was 22.60K shares, 0.3x its 50-day average of 70.49K β lighter than usual.
- Price is -16.7% vs its 50-day average ($12.58) and -29.2% vs its 200-day average ($14.80).
- 52-week range $8.41β$29.00; today's close sits at 10% of that range, 63.9% below the 52-week high.
VHC latest news & SEC filings
Every SEC filing by or about VHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Angelo Michael F sold 1,000 shares at $10.26 (β$10.26K) on Sep 30, 2026; now holds 28,209
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
Oct 1, 2026 Β· Form 424B5 β Prospectus supplement
Prospectus supplement β the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 29, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Larsen Kendall sold 4,425 shares at $11.17 (β$49.43K) on Sep 14, 2026
- Larsen Kendall sold 8,000 shares at $11.37 (β$90.96K) on Sep 11, 2026
- Larsen Kendall sold 8,000 shares at $11.48 (β$91.84K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Larsen Kendall sold 4,057 shares at $11.43 (β$46.37K) on Sep 2, 2026
- Larsen Kendall sold 518 shares at $12.13 (β$6.28K) on Sep 2, 2026
- Larsen Kendall sold 5,000 shares at $11.00 (β$55.00K) on Sep 1, 2026
- Larsen Kendall sold 5,000 shares at $11.17 (β$55.85K) on Aug 31, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Feiner Gary sold 3,750 shares at $11.00 (β$41.25K) on Sep 1, 2026
- Feiner Gary sold 3,749 shares at $11.17 (β$41.88K) on Aug 31, 2026
- Feiner Gary sold 1 shares at $12.03 (β$12) on Aug 31, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 27, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $48.00K) (-100.0% vs Jun 30, 2025)
- Net income: -$4.53M (prior year -$3.62M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.20 (prior year -$0.99) (loss widened vs Jun 30, 2025)
Things to know before you trade VHC
- Last results release: Oct 19, 2017 (8-K Item 2.02). Previous ones: Aug 9, 2010. Based on that rhythm, the next report is likely around Jan 18, 2018 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.48% (largest 15.3%). That is a volatile stock.
- Liquidity: about 39.24K shares (β$431.30K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.99 vs a range of $8.41β$29.00 (13% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 12 sales; latest: Kendall Larsen sold 4,425 shares on Sep 14, 2026.
- Latest filings: 8-K Oct 1, 2026; 10-Q Aug 14, 2026; 8-K Jun 16, 2026.
- Share count: 4.22M shares outstanding (Aug 7, 2026), -1.3% vs a year earlier.
- Listing: Nasdaq Β· industry: Patent Owners & Lessors.
VHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 10.91 | 11.05 | 10.91 | 10.99 | 4.80K |
| Oct 14, 2026 | 10.90 | 11.08 | 10.78 | 10.91 | 8.20K |
| Oct 13, 2026 | 11.09 | 11.11 | 10.25 | 10.96 | 10.60K |
| Oct 12, 2026 | 11.34 | 11.58 | 10.31 | 11.02 | 12.20K |
| Oct 9, 2026 | 11.79 | 12.60 | 11.22 | 11.50 | 17.00K |
| Oct 8, 2026 | 11.34 | 12.42 | 11.34 | 12.30 | 40.90K |
| Oct 7, 2026 | 11.99 | 12.00 | 11.15 | 11.81 | 19.30K |
| Oct 6, 2026 | 11.43 | 12.01 | 11.39 | 11.96 | 13.30K |
| Oct 5, 2026 | 10.38 | 11.74 | 10.38 | 11.32 | 14.20K |
| Oct 2, 2026 | 9.51 | 10.48 | 9.51 | 10.48 | 22.60K |
| Oct 1, 2026 | 9.86 | 9.97 | 8.41 | 9.38 | 51.90K |
| Sep 30, 2026 | 10.19 | 10.65 | 10.00 | 10.19 | 35.80K |
| Sep 29, 2026 | 10.26 | 10.34 | 10.15 | 10.32 | 4.60K |
| Sep 28, 2026 | 10.30 | 10.54 | 10.11 | 10.23 | 18.70K |
| Sep 25, 2026 | 12.24 | 12.47 | 10.00 | 10.36 | 94.50K |
| Sep 24, 2026 | 12.90 | 12.90 | 11.83 | 12.23 | 69.20K |
| Sep 23, 2026 | 12.35 | 12.85 | 12.15 | 12.65 | 82.70K |
| Sep 22, 2026 | 13.03 | 13.44 | 12.10 | 12.40 | 75.80K |
| Sep 21, 2026 | 12.05 | 13.11 | 11.81 | 12.95 | 167.00K |
| Sep 18, 2026 | 11.40 | 12.01 | 10.96 | 12.00 | 21.60K |
About VirnetX
VirnetX (VHC) is listed on the Nasdaq and classified by the SEC under βPatent Owners & Lessorsβ. Its business address is in ZEPHYR COVE, NV. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1082324.
VHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Michael F Angelo | Director | Jun 15, 2026 |
| Heidy Kingwan Chow | Director | Jun 15, 2026 |
| Gary Feiner | Director | Sep 2, 2026 |
| Kendall Larsen | President & CEO | Sep 14, 2026 |
| Thomas M O'Brien | Director | Jun 25, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Katherine Allanson | Chief Financial Officer | Jul 13, 2026 |
| Kendall Larsen | President & CEO | Sep 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | Kendall Larsen | Sale | 4,425 | $11.17 |
| Sep 11, 2026 | Kendall Larsen | Sale | 8,000 | $11.37 |
| Sep 10, 2026 | Kendall Larsen | Sale | 8,000 | $11.48 |
| Sep 2, 2026 | Kendall Larsen | Sale | 4,057 | $11.43 |
| Sep 2, 2026 | Kendall Larsen | Sale | 518 | $12.13 |
| Sep 1, 2026 | Kendall Larsen | Sale | 5,000 | $11.00 |
| Sep 1, 2026 | Gary Feiner | Sale | 3,750 | $11.00 |
| Aug 31, 2026 | Kendall Larsen | Sale | 5,000 | $11.17 |
| Aug 31, 2026 | Gary Feiner | Sale | 3,749 | $11.17 |
| Aug 31, 2026 | Gary Feiner | Sale | 1 | $12.03 |
| Nov 26, 2025 | Gary Feiner | Sale | 1,875 | $22.70 |
| Nov 24, 2025 | Michael F Angelo | Sale | 625 | $20.89 |
VHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $162.00K | $-18.23M | -5.00 | $-15.64M |
| Dec 31, 2024 | $5.00K | $-18.18M | -5.05 | $-15.33M |
| Dec 31, 2023 | $7.00K | $-27.87M | -7.79 | $-24.77M |
| Dec 31, 2022 | $48.00K | $-36.26M | -10.17 | $-16.89M |
| Dec 31, 2021 | $35.00K | $-42.92M | -0.60 | $-51.72M |
Latest balance sheet: total assets $22.97M, total liabilities $7.91M, cash $13.09M (as of Jun 30, 2026).
VHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 19, 2017 | 8-K Item 2.02 (results) | β |
| Aug 9, 2010 | 8-K Item 2.02 (results) | β |
Related stocks Β· Patent Owners & Lessors
InterDigital (IDCC)Alpha Modus (AMOD)Dolby Laboratories (DLB)Digital Turbine (APPS)Acacia Research (ACTG)Joint (JYNT)Research Frontiers (REFR)Royalty Management (RMCO)XCel Brands (XELB)Network-1 Technologies (NTIP)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on VHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.